Warfarin-Aspirin Recurrent Stroke study (WARSS) Trial - Is Warfarin Really a Reasonable Therapeutic Alternative to Aspirin for Preventing Recurrent Noncardioembolic Ischemic Stroke

Research output: Contribution to journalReview article

41 Citations (Scopus)
Original languageEnglish
Pages (from-to)1723-1726
JournalStroke
Volume33
DOIs
Publication statusPublished - 2002

Cite this